See All Slides - tctmd.com

Slides

Presentation TCT 2013

Case #5: An Impossible Case I Succeeded that Changed my Practice

Presenter: Evald Christiansen

October 28, 2013

Presentation TCT 2013

Lessons About the Subintimal Space from J-Proctor

Presenter: Etsuo Tsuchikane

October 28, 2013

Presentation TCT 2013

University-Based Technology Transfer

Presenter: Karin Immergluck

October 28, 2013

Presentation TCT 2013

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Presenter: Maurice Sarano

October 28, 2013

Presentation TCT 2013

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Case #8: Why I Attempted an RCA CTO Five Times (And What I Did Different to Succeed)

Presenter: William Lombardi

October 28, 2013

Presentation TCT 2013

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Presenter: Eugene Blackstone

October 28, 2013

Presentation TCT 2013

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Risk Stratification and When to Cath

Presenter: Kevin Beatt

October 28, 2013

Advertisement

Slides

Case #5: An Impossible Case I Succeeded that Changed my Practice

Lessons About the Subintimal Space from J-Proctor

University-Based Technology Transfer

Yes! The Pathophysiology Dictates This and the Outcomes Data Are Clear

Determinants and Outcomes of Acute Valve-in-Valve Therapy or Valve Embolization During TAVR: A PARTNER Substudy

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Case #8: Why I Attempted an RCA CTO Five Times (And What I Did Different to Succeed)

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Risk Stratification and When to Cath

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content